These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16649834)

  • 41. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
    Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
    JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The long-term effectiveness of clozapine and lamotrigine in a patient with treatment-resistant rapid-cycling bipolar disorder.
    Bastiampillai TJ; Reid CE; Dhillon R
    J Psychopharmacol; 2010 Dec; 24(12):1834-6. PubMed ID: 20142304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
    Suppes T; Eudicone J; McQuade R; Pikalov A; Carlson B
    J Affect Disord; 2008 Apr; 107(1-3):145-54. PubMed ID: 17904226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clozapine treatment of euphoric mania.
    Antonacci DJ; Swartz CM
    Ann Clin Psychiatry; 1995 Dec; 7(4):203-6. PubMed ID: 8721894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder.
    Wu CS; Hsieh MH; Tang CH; Chang CJ
    J Affect Disord; 2016 Jun; 197():189-95. PubMed ID: 26994437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of predominant polarity on long-term outcome in bipolar disorder: A 7-year longitudinal cohort study.
    Belizario GO; Silva M; Lafer B
    J Affect Disord; 2018 Dec; 241():37-40. PubMed ID: 30096590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The long-term natural history of the weekly symptomatic status of bipolar I disorder.
    Judd LL; Akiskal HS; Schettler PJ; Endicott J; Maser J; Solomon DA; Leon AC; Rice JA; Keller MB
    Arch Gen Psychiatry; 2002 Jun; 59(6):530-7. PubMed ID: 12044195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study.
    Nielsen J; Kane JM; Correll CU
    Bipolar Disord; 2012 Dec; 14(8):863-9. PubMed ID: 23107278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
    Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
    Lähteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J
    JAMA Psychiatry; 2018 Apr; 75(4):347-355. PubMed ID: 29490359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and therapeutic implications of predominant polarity in bipolar disorder.
    Colom F; Vieta E; Daban C; Pacchiarotti I; Sánchez-Moreno J
    J Affect Disord; 2006 Jul; 93(1-3):13-7. PubMed ID: 16650901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clozapine in the treatment of refractory psychotic mania.
    Green AI; Tohen M; Patel JK; Banov M; DuRand C; Berman I; Chang H; Zarate C; Posener J; Lee H; Dawson R; Richards C; Cole JO; Schatzberg AF
    Am J Psychiatry; 2000 Jun; 157(6):982-6. PubMed ID: 10831480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
    Angst J; Azorin JM; Bowden CL; Perugi G; Vieta E; Gamma A; Young AH;
    Arch Gen Psychiatry; 2011 Aug; 68(8):791-8. PubMed ID: 21810644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clozapine treatment in a population of adults with mental retardation.
    Antonacci DJ; de Groot CM
    J Clin Psychiatry; 2000 Jan; 61(1):22-5. PubMed ID: 10695641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study.
    González-Pinto A; Alberich S; Barbeito S; Alonso M; Vieta E; Martínez-Arán A; Saenz M; López P
    J Affect Disord; 2010 Aug; 124(3):250-5. PubMed ID: 19959240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
    Geoffroy PA; Bellivier F; Henry C
    Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preventive effect of aripiprazole once monthly on rehospitalization for bipolar disorder: A multicenter 1-year retrospective mirror image study.
    Goto J; Shono M; Abe Y; Fujita Y; Ueda K; Yoshida B; Nabeshima Y
    Neuropsychopharmacol Rep; 2023 Sep; 43(3):425-433. PubMed ID: 37560818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.